RARA CRAFT DATABASE for FDA Medical Devices
PMAP210037

FDA DEVICE FACTS

Prospera Spinal Cord Stimulation (SCS) System, Resilience Percutaneous Lead, HomeStream Remote Management

Biotronik Nro, Inc.

Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。

DECISION DATEMarch 31, 2023PRODUCT CODELGW

Indications for use

The Prospera Spinal Cord Stimulation (SCS) system is indicated as an aid in the management of chronic, intractable pain in the trunk and/or limbs, which may include unilateral or bilateral pain, resulting from any of the following:

• Failed Back Syndrome (FBS) or low back syndrome or failed back

• Radicular pain syndrome or radiculopathies resulting in pain secondary to FBS or herniated disk

• Postlaminectomy pain

• Multiple back operations

• Unsuccessful disk surgery

• Degenerative Disk Disease (DDD)/herniated disk pain refractory to conservative and surgical interventions

• Peripheral causalgia

• Epidural fibrosis

• Arachnoiditis or lumbar adhesive arachnoiditis

• Complex Regional Pain Syndrome (CRPS), Reflex Sympathetic Dystrophy (RSD), or causalgia.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 2, 2026